Jim Faulkner is an Independent Consultant at JDB BioConsulting. Prior to this, Jim held various leadership positions at companies such as Ascidian Therapeutics, Apple Tree Partners, Autolus Ltd., GlaxoSmithKline, British Biotech, CAMR, and Vrije Universiteit Amsterdam. Jim's expertise lies in biopharmaceutical analysis, product delivery, and early stage biopharm development. Jim's education background includes studies at the University of Leeds.
January 1, 2024 - present
April, 2020